2014NovPhD326/BBC_/Breast Cancer Now/United Kingdom[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2019	2
2020	1
2025	0

Page 1

EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.

Mahmud Z, Gomes AR, Lee HJ, Aimjongjun S, Jiramongkol Y, Yao S, Zona S, Alasiri G, Gong G, Yagüe E, Lam EW. Mahmud Z, et al. Cancers (Basel). 2019 Jul 28;11(8):1067. doi: 10.3390/cancers11081067. Cancers (Basel). 2019. PMID: 31357743 Free PMC article.

Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer.

Azenha D, Hernandez-Perez S, Martin Y, Viegas MS, Martins A, Lopes MC, Lam EW, Freire R, Martins TC. Azenha D, et al. Cancers (Basel). 2020 Aug 24;12(9):2396. doi: 10.3390/cancers12092396. Cancers (Basel). 2020. PMID: 32847043 Free PMC article.

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.

Aimjongjun S, Mahmud Z, Jiramongkol Y, Alasiri G, Yao S, Yagüe E, Janvilisri T, Lam EW. Aimjongjun S, et al. BMC Cancer. 2019 Nov 14;19(1):1106. doi: 10.1186/s12885-019-6308-7. BMC Cancer. 2019. PMID: 31727006 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year